用于临床研究的光敏D-LSD囊的稳定性导向配方
Bernard Do1,2, Luc Mallet3,4,5, Maxime Annereau1,2
1Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94805 Villejuif, France.
Pharmaceutics
|June 27, 2025
概括
一个新的液体填充囊可以保护D-lysergic acid diethylamide (D-LSD) 免受光线的影响,解决其用于治疗酒精使用障碍 (AUD) 的关键挑战. 这种光稳定配方对于未来的临床试验至关重要.
科学领域:
- 制药科学 制药科学
- 药用化学 医学化学
- 分析化学 分析化学
背景情况:
- D-lysergic acid diethylamide (D-LSD) 显示出对酒精使用障碍 (AUD) 的治疗潜力.
- D-LSD极度的光敏感性阻碍了药物开发和临床应用.
- 开发一种光稳定的D-LSD配方对于其作为试验药物的发展至关重要.
研究的目的:
- 开发和描述D-LSD的液体填充囊配方.
- 为了保护D-LSD在储存和处理期间免受光降解.
- 为了确保准确的剂量和适合AUD治疗临床试验.
主要方法:
- 利用了多层次的分析策略,包括液态色谱与离子移动性谱学和质谱学 (LC-IM-MS) 相结合.
- 使用量子化学计算 (DFT和TD-DFT) 进行降解产品的结构特征.
- 在符合ICH的条件下进行光应力研究,以评估配方的稳定性.
主要成果:
- 溶液中的D-LSD在暴露于光线时迅速降解为光异构体和光氧化副产品.
- 拟议的液体填充囊配方显著减轻了DLSD光降解.
- 坐标稳定性分析证实了囊的光保护功效.
结论:
- 开发的囊配方为D-LSD提供了一个可行的,光稳定的平台.
- 正角稳定性分析对于指导药物配方开发至关重要.
- 这种配方支持D-LSD对酒精使用障碍的未来临床研究.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
336
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
336
Clinically Relevant Drug Product Specifications: Methods of Establishment
303
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
303
Drug Product Stability
376
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
376
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
421
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
421


